Price: $97.9
· 1 day: -0.10% · 5 days: -0.80% · 1 month: +8.84% · YTD: +23.89%
As of 2026-11-12 21:00 UTC.
52-week range: $75.96 – $101.18 (currently at 87% of the range).
CL is in an uptrend, momentum firm. $99.14 is the level overhead; $97.81 the first support below.
5 of 6 technical checks lean bullish.
| Trend | Uptrend · above 50-day & 200-day |
|---|---|
| Momentum | RSI 61.2 · MACD bullish |
| Trend strength | ADX 38.7 · strong trend |
| Location | +7.9% vs 50-day MA |
| 52-week range | -1% from high · +29% from low |
| Volatility | ATR 2.3 · ~2.3%/day |
| Level | Type | Distance |
|---|---|---|
| $99.14 (resistance) | 52w high | 1.27% |
| $100.0 (resistance) | round | 2.15% |
| $110.0 (resistance) | round | 12.36% |
| $97.81 (support) | swing zone | -0.09% |
| $95.8 (support) | swing zone | -2.15% |
| $93.21 (support) | swing zone | -4.79% |
| RSI (14) | 61.19 | MACD | 2.1097 |
|---|---|---|---|
| ADX (14) | 38.7 | ATR (14) | 2.3 |
| 50-day average | $90.77 | 200-day average | $90.24 |
Next earnings: 2027-01-29. CL earnings date, time and past reactions.
Report of 2026-11-03.
Colgate-Palmolive (CL) trades at $95.66 after a third-quarter report that expanded margins and raised earnings guidance. The balance of evidence leans positive for the next 2–6 weeks, with high conviction (3 of 4 points). The weekly and daily trends agree, and CL is leading both the S&P 500 and consumer staples. The breakout math from $95.80 does not reach 3 to 1, though, so the setup is better than the entry.
On October 30, 2026, CL reported net sales of $5.369 billion, up 4.6%, with organic growth of 3.6%. Base business earnings per share rose 7% to $0.97, and gross margin widened 90 basis points to 60.3%. Management narrowed full-year sales guidance to 4–5% growth and raised its EPS guidance, according to the call transcript. The margin is what mattered. Staples companies have been fighting input-cost inflation, and CL showed it can price and save its way through.
The market paid for that quickly. Shares rose nearly 5% in early trading. CL was also among the top S&P 500 performers that Friday as money left technology. The stock then peaked at a $97.43 close on November 2 and is up 13.7% over a month. Today it is down 1.82%, about 1.8% off that peak. The contrast with the peer backdrop explains why the beat was valued: on November 2, Clorox cut its margin outlook after its weakest gross margin in three years. That is a different company, but it shows the cost pressure CL's 60.3% margin stands out against.
Most of the five-day move was the market and the sector, not CL alone. CL gained 3.98% over five days while the S&P 500 fell 2.06% and XLP, the staples fund, rose 2.42%. Defensives caught the money leaving tech, and CL's own contribution was the 1.6 points by which it beat XLP. Today's slip fits that pattern: CL fell 1.82% and XLP fell 1.73% while the S&P 500 rose 0.23%. That is the sector giving back part of the rotation. No CL-specific news explains today's drop.
The argument about CL is whether the margin story deserves a higher multiple. The bullish case, made on Seeking Alpha, is that higher gross margin guidance could expand the valuation multiple. A more cautious author keeps a Hold rating, saying the fundamentals support owning the stock but the valuation limits new money. The Motley Fool frames CL against Celsius, whose revenue grew 85.5%, which is a growth argument against a defensive compounder. Analysts sit mostly on the bullish side: 20 cover the stock with a buy consensus and a mean price target of $101.7. The stock is 5.9% below that mean, inside a spread of $88 to $112.
The long-term thesis is intact. Price is above both its 10-week and 40-week averages and is up 21.3% year to date, against 10.5% for the S&P 500. The 50-day average at $89.74 and the 200-day at $89.80 have converged, and the stock has lifted well clear of both. It sits 3.5% below its 52-week high of $99.14, in the advancing phase of an uptrend and not yet in a stretched one: RSI is 56.6.
For the next 2–6 weeks the evidence leans positive, and conviction is high at 3 of 4 points. The daily trend runs with the weekly uptrend. CL is ahead of the S&P 500 by 8.4% over 50 days and ahead of XLP by 1.3%. That second comparison matters most: the stock is beating its own sector, not just riding it.
The strongest case against is that much of the recent gain came from rotation. If tech rebounds and defensives give back more, CL would feel it, as today's 1.73% drop in XLP showed. The reward math is also thin, with targets at 0.6 and 1.0 times the risk. Volume is running 40.7% below its 20-day average, so the pullback has been quiet, which is mildly reassuring. These are the kinds of evidence that keep conviction from being higher. They do not tip the balance, because the trend structure and the relative leadership both still point the same way.
The structure holds above $92.98, a swing zone, and the first crack in the picture is a break below it. The trend itself ends below $89.30, another swing zone, and the round $90 level sits just above it as extra support. Below $89.30 the next supports are $86.44 and $84.12.
The breakout level is a daily close above $95.80 on volume above its 20-day average. From there the first target is $97.81, a swing zone, at 0.6 times the risk, and the second is the 52-week high of $99.14, at 1.0 times. The stop is $92.41, which is $92.98 less a quarter of the 2.3 average daily range. The math does not reach 3 to 1. Only a target far above the 52-week high would change that. Of the mapped levels, only $110 is far enough; $100 is not.
A weekly close below $89.30 would change the picture. It would break the swing zone that marks the end of the uptrend. The non-price fact most likely to cause it is evidence that cost inflation is reaching CL's gross margin, such as a margin guidance cut like Clorox's. CL's recent results rest on that margin holding at 60.3%, and the thesis weakens if it does not.
Interactive CL chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs